HOUSE_OVERSIGHT_024760.jpg
1.1 MB
Extraction Summary
0
People
12
Organizations
1
Locations
0
Events
0
Relationships
2
Quotes
Document Information
Type:
Financial report / investment report
File Size:
1.1 MB
Summary
This document is page 124 of a 'Cannabis Investment Report' dated December 2017, produced by Ackrell Capital. It contains financial tables listing market data (stock price, market value, enterprise value, revenue, EBITDA) for various cannabis-related companies listed on Nasdaq, NYSE, and AMEX as of November 30, 2017. The document bears a 'HOUSE_OVERSIGHT_024760' stamp, indicating it is part of a larger production of documents to the House Oversight Committee.
Organizations (12)
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC |
Investment firm issuing the report
|
|
| House Oversight Committee |
Indicated by the 'HOUSE_OVERSIGHT' stamp
|
|
| Cara Therapeutics, Inc. |
Nasdaq listed cannabis-related company
|
|
| GW Pharmaceuticals plc |
Nasdaq listed cannabis-related company
|
|
| INSYS Therapeutics, Inc. |
Nasdaq listed cannabis-related company
|
|
| Zynerba Pharmaceuticals, Inc. |
Nasdaq listed cannabis-related company
|
|
| 22nd Century Group, Inc. |
AMEX listed cannabis-related company
|
|
| India Globalization Capital, Inc. |
AMEX listed cannabis-related company
|
|
| Innovative Industrial Properties, Inc. |
NYSE listed cannabis-related company
|
|
| Constellation Brands, Inc. |
NYSE listed ancillary company
|
|
| The Scotts Miracle-Gro Company |
NYSE listed ancillary company
|
|
| S&P Global Market Intelligence |
Provider of the financial data
|
Locations (1)
| Location | Context |
|---|---|
|
Location of NYSE and AMEX exchanges implied
|
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document